|
|
|
Corporate Profile: Peptagen
| Summary: |
Peptagen is focused on the development cytotoxic T-lymphocyte (CTL) vaccines for infectious diseases and cancer via nasal nanoparticle-enabled delivery.
|
| Address (HQ): |
4100 City of Oaks Wynd
Suite 100
Raleigh, NC 27612 |
| Phone #'s (HQ): |
| Main |
(919) 851-4870 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax #'s (HQ): |
| Main |
(919) 851-4868 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| not known |
| Internet
job postings: |
| not known |
| Number
of employees: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
